The risk of Wound Healing Complications (WHC) and the early use of mTORi after Kidney Transplantation (KT) have not been fully addressed.
A 3-month, multicenter, randomized, open-label study to evaluate the impact on wound healing of the early [vs. delayed] introduction of everolimus in de novo kidney transplant recipients, with a follow-up evaluation at 12 month after transplant (NEVERWOUND study) / Manzia, T.M., Carmellini, M., Todeschini, P., Secchi, A., Sandrini, S., Minetti, E., Furian, L., Spagnoletti, G., Pisani, F., Piredda, G.B., Cappelli, G., Tisone, G.. - In: TRANSPLANTATION. - ISSN 0041-1337. - 104:2(2020), pp. 374-386. [10.1097/TP.0000000000002851]
A 3-month, multicenter, randomized, open-label study to evaluate the impact on wound healing of the early [vs. delayed] introduction of everolimus in de novo kidney transplant recipients, with a follow-up evaluation at 12 month after transplant (NEVERWOUND study)
Cappelli, GianniMembro del Collaboration Group
;
2020
Abstract
The risk of Wound Healing Complications (WHC) and the early use of mTORi after Kidney Transplantation (KT) have not been fully addressed.
| File | Dimensione | Formato | |
|---|---|---|---|
|
TPA-2019-0006-2.pdf
Open access
Tipologia:
AAM - Versione dell'autore revisionata e accettata per la pubblicazione
Dimensione
1.16 MB
Formato
Adobe PDF
|
1.16 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
